Allosteric inhibition of the proteasome.

被引：0
|
作者：
Kisselev, AF [1 ]
机构：
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 222卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
156-MEDI
引用
收藏
页码：U665 / U665
页数：1
相关论文
共 50 条
  • [21] Substrate modification by 4-hydroxynonenal modulates degradation by the 26S proteasome.
    Carbone, DL
    Doorn, JA
    Petersen, DR
    TOXICOLOGICAL SCIENCES, 2003, 72 : 196 - 196
  • [22] A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome.
    Holzhütter, HG
    Frömmel, C
    Kloetzel, PM
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (04) : 1251 - 1265
  • [23] Rpn7p is required for the assembly of the lid of the yeast 26S proteasome.
    Isono, E
    Saeki, Y
    Yokosawa, H
    Toh-e, A
    YEAST, 2003, 20 : S148 - S148
  • [24] Proteasome inhibition and Aβ production
    Johnston, JA
    Lynas, JF
    Walker, B
    Flood, FM
    Jensen, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S178 - S178
  • [25] Metabolism, disposition and pharmacokinetics of PR-171, a novel inhibitor ofthe 20S proteasome.
    Yang, Jinfu
    Fonseca, Fabiana
    Ho, Mark
    Kirk, Christopher J.
    Sehl, Louis S.
    Lewis, Evan R.
    BLOOD, 2006, 108 (11) : 356B - 356B
  • [26] Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function. Essential role of the proteasome.
    Powell, S
    Wang, P
    Katzeff, H
    Shringarpure, R
    Teoh, C
    Khaliulin, I
    Das, D
    Davies, K
    Schwalb, H
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 : S185 - S186
  • [27] Functional studies of the ATP-binding subunits of PA700, an activator of 20S proteasome.
    Zagnitko, OP
    DeMartino, GN
    Slaughter, CA
    FASEB JOURNAL, 1996, 10 (06): : 2942 - 2942
  • [28] Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
    Xolalpa, Wendy
    Perez-Galan, Patricia
    Rodriguez, Manuel S.
    Roue, Gael
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (22) : 4053 - 4093
  • [29] Design and synthesis of novel protease inhibitors. Tripeptide alpha',beta'-epoxyketones as nanomolar inactivators of the proteasome.
    Spaltenstein, A
    Leban, JJ
    Huang, JJ
    Reinhardt, KR
    Viveros, OH
    Sigafoos, J
    Crouch, R
    TETRAHEDRON LETTERS, 1996, 37 (09) : 1343 - 1346
  • [30] Pharmacokinetics, pharmacodynamics and anti-tumor efficacy of PR-171, a novel inhibitor of the 20S proteasome.
    Kirk, CJ
    Bennett, MK
    Buchholz, TJ
    Demo, SD
    Ho, MN
    Jiang, J
    Laidig, GJ
    Lewis, ER
    Shenk, KD
    Smyth, MS
    Sun, CM
    Vallone, MK
    Woo, TM
    Molineaux, CJ
    BLOOD, 2005, 106 (11) : 181A - 181A
12345